Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …

Objectives We evaluated the clinical, virological and safety outcomes of lopinavir/ritonavir,
lopinavir/ritonavir–interferon (IFN)-β-1a, hydroxychloroquine or remdesivir in comparison to …

Lung cancer is an important complication associated with chronic HIV infection. It is
associated with unique HIV-related causal mechanisms, and may be associated with worse …

Discussion To date, treatment of COVID-19 is still challenging and there is no specific
recommended therapy. Despite the sequential introduction of different treatments, our patient …

Blood collected and dried on a paper card – dried blood spot (DBS) – knows a growing interest
as a sampling method that can be performed outside care facilities by capillary puncture, …

We assessed the expression of CD169, a type I interferon-inducible receptor, on monocytes
(monocyte CD169 [mCD169]) in 53 adult patients admitted to the hospital during the …

Background Intermittent (on 4 days per week) antiretroviral therapy (ART) for patients with
HIV-1 might be more convenient, better tolerated, and cheaper than continuous treatment. We …

Environmental factors such as chemicals, stress and pathogens are now widely believed to
play important roles in the onset of some brain diseases, as they are associated with …

Management of relapsing or refractory immune reconstitution inflammatory syndromes (IRISs)
despite corticosteroid therapy is yet to be defined. We describe three HIV-infected patients …

Objectives To assess the efficacy of inhaled ciclesonide in reducing the risk of adverse
outcomes in COVID-19 outpatients at risk of developing severe illness. Methods COVERAGE is …